Skip to main content
Advertisement
Advertisement
CLOV
CLOV logo
Clover Health Investments, Corp
4.56
USD
Sponsored
-0.04
-0.87%
Oct 26, 15:59 UTC -4
Closed
exchange

After-Market

4.57

+0.01
+0.11%

Clover Health Investments, Corp (CLOV) Earnings

CLOV Earnings Reports

Positive Surprise Ratio

CLOV beat 17 of 22 last estimates.

77%

Next Report

Date of Next Report
Nov 04, 2026
Estimate for Q3 26 (Revenue/ EPS)
$752.95M
/
$0.00
Implied change from Q2 26 (Revenue/ EPS)
+1.32%
/
-100.00%
Implied change from Q3 25 (Revenue/ EPS)
+51.61%
/
-100.00%

Clover Health Investments, Corp earnings per share and revenue

On Aug 05, 2026, CLOV reported earnings of 0.05 USD per share (EPS) for Q2 26, beating the estimate of 0.03 USD, resulting in a 47.06% surprise. Revenue reached 743.17 million, compared to an expected 742.83 million, with a 0.05% difference. The market reacted with a +12.56% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 0.00 USD, with revenue projected to reach 752.95 million USD, implying an decrease of -100.00% EPS, and increase of 1.32% in Revenue from the last quarter.
FAQ
For Q2 2026, Clover Health Investments, Corp reported EPS of $0.05, beating estimates by 47.06%, and revenue of $743.17M, 0.05% above expectations.
The stock price moved up 12.56%, changed from $4.14 before the earnings release to $4.66 the day after.
The next earning report is scheduled for Nov 04, 2026.
Based on -- analysts, Clover Health Investments, Corp is expected to report EPS of -- and revenue of $752.95M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement